CVR number 29149410
Industry 72.2000 Research and experimental development on social sciences and humanities

UGGEBAI ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  5.7% 5.9% 7.5% 5.0% 3.6%  
Credit score (0-100)  41 39 31 43 51  
Credit rating  BBB BBB BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  -54.2 -33.5 -55.8 -36.0 -31.1  
EBITDA  -54.2 -33.5 -55.8 -36.0 -31.1  
EBIT  -54.2 -33.5 -55.8 -36.0 -31.1  
Pre-tax profit (PTP)  222.2 187.2 -836.9 -27.4 506.6  
Net earnings  171.9 145.6 -654.5 -22.2 394.5  
Pre-tax profit without non-rec. items  222 187 -837 -27.4 507  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,535 1,567 798 776 1,171  
Interest-bearing liabilities  13.9 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,601 1,657 852 789 1,183  
Net Debt  -1,583 -1,653 -670 -597 -1,108  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -54.2 -33.5 -55.8 -36.0 -31.1  
Gross profit growth  0.0% 38.1% -66.6% 35.6% 13.6%  
Employees  0 0 0 0 0  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,601 1,657 852 789 1,183  
Balance sheet change%  -0.9% 3.5% -48.6% -7.4% 50.0%  
Added value  -54.2 -33.5 -55.8 -36.0 -31.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  14.1% 11.7% -4.4% -3.1% 51.4%  
ROI %  14.5% 12.2% -4.7% -3.2% 52.0%  
ROE %  11.0% 9.4% -55.3% -2.8% 40.5%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  95.8% 94.6% 93.7% 98.4% 98.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  2,920.6% 4,931.1% 1,199.2% 1,659.8% 3,564.7%  
Gearing %  0.9% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  73.5% 36.7% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  24.1 18.5 15.9 62.9 94.6  
Current Ratio  24.1 18.5 15.9 62.9 94.6  
Cash and cash equivalent  1,596.6 1,652.8 669.5 597.0 1,107.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  269.4 584.2 284.8 293.3 118.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0